Industry News
Good dose for Viralytics
Viralytics progresses through Phase 1 trial of Cavatak [ + ]
Anadis fights flu
Anadis shows proof-of-principle for spray-based 'flu fighter' [ + ]
Investment boost for UniQuest start-up companies
Two companies that were established to develop discoveries from the Australian Institute for Bioengineering and Nanotechnology (AIBN) at UQ have received funding to boost their research priorities.
[ + ]US Pharmacopeia achieves ISO accreditation for Certified Reference Materials
The US Pharmacopeial Convention has achieved accreditation from ACLASS to the ISO Guide 34 for reference material producers as an internationally accredited producer of Certified Reference Materials.
[ + ]Aldridge quits Peplin
Peplin appoints new CEO and president/CMO [ + ]
Patent no loss of MatrixView
MatrixView awarded European patent for data management technology [ + ]
$3 million for Chagas research
Murdoch University and Epichem get $3 million Chagas research boost [ + ]
Genentech rejects Roche bid
US biotech Genentech rejects $43.7 billion takeover deal [ + ]
Acrux-Organon partnership dropped
Schering-Plough cancels two projects with Acrux [ + ]
Life's Full Court appeal accepted
Life's legal battle with Bell IXL will continue, after the Full Court ordered a retrial. [ + ]
Stalling PTKs in their tracks
An enzyme called TCPTP keeps a tight rein on damaged DNA [ + ]
Acrux heads to the Finnish
Acrux signs exclusive manufacturing partner for Testosterone MD-Lotion [ + ]
Circadian owns Vegenics
Circadian finalises Vegenics purchase [ + ]
Biotron expands HCV trial
Biotron adds Brisbane site for hep C clinical trial [ + ]
Next trial for Starpharma
Starpharma studies VivaGel duration [ + ]
